Papers
7
Total Citations
96
H-Index
6
About
Dr. L. Di Gianfrancesco is a leading urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for bladder and prostate cancer, with a particular focus on improving functional outcomes and reducing postoperative morbidity. His major contributions include pioneering techniques in robot-assisted radical cystectomy (RARC) with intracorporeal neobladder reconstruction, where he has systematically documented urinary continence and erectile function recovery in both male and female patients. His highly cited 2023 study on functional outcomes after RARC with orthotopic neobladder (32 citations) is a landmark reference in the field. Dr. Gianfrancesco has also been instrumental in large-scale collaborative efforts, including the Italian Radical Cystectomy Registry, which analyzed intraoperative outcomes across 1,400 patients, and the EAU Robotic Urology Section working group on reducing morbidity after neobladder surgery. Beyond surgical innovation, he demonstrated adaptability and leadership during the COVID-19 pandemic, authoring a widely read paper on how the crisis could catalyze positive changes in urology residency training (22 citations). His work on rare complications, such as Hem-o-Lok clip migration, further showcases his commitment to patient safety. With a growing citation record and active involvement in multi-institutional databases, Dr. Gianfrancesco is shaping the future of minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency?22 citations · 2020
- 3
- 4
- 5
- 6
- 7